Endorectal balloon with gas release lumen

ABSTRACT

A rectal balloon apparatus comprises a shaft having a fluid passageway extending therethrough. A rectal gas relieving lumen may be positioned with a central shaft for removal of rectal gas. The gas releasing lumen can also or in the alternative be provided along an outer surface of the balloon. A motion detecting sensor and a radiation detecting sensor may be positioned with the balloon, the shaft, and/or the rectal gas release lumen.

PRIOR RELATED APPLICATIONS

This application is a continuation-in-part of each of the followingco-pending U.S. Applications, all of which are hereby incorporated byreference for all purposes in their entirety: Ser. No. 11/623,702 filedon Jan. 16, 2007; Ser. No. 11/933,018 filed on Oct. 31, 2007; Ser. No.11/966,544 filed on Dec. 28, 2007; Ser. No. 12/034,470 filed on Feb. 20,2008; Ser. No. 12/141,270 filed on Jun. 18, 2008; Ser. No. 12/410,639filed on Mar. 25, 2009; Ser. No. 12/412,017 filed on Mar. 26, 2009; andSer. No. 13/299,348 filed Nov. 17, 2011.

FIELD OF THE DISCLOSURE

The present disclosure relates to rectal balloons that are used forimmobilizing the region surrounding the prostate.

BACKGROUND OF THE DISCLOSURE

Treatment of prostate cancer using radiation therapy is difficult due tothe prostate's position near radiation-sensitive tissues, and is furthercomplicated by prostate motion. Adenocarcinoma of the prostate commonlyoccurs in the posterior portion of the prostate gland, which is in veryclose proximity to the rectal wall. To date, external beam radiationtreatment, urethrograms, CT scans and magnetic resonance imaging (MRI)have all been used to visually localize the prostate, as well as thenormal critical structures in the surrounding area.

U.S. Pat. No. 5,476,095 proposes an insertable pickup probe for use inproviding diagnostic MRI images. The pickup probe, in its preferredembodiment, is proposed for use in imaging the male prostate andcomprises an elongated shaft supporting an inflatable patient interfaceballoon at its distal end. The interface balloon comprises an innerballoon and an outer balloon, between which a receiving coil ispositioned. A lumen for air supply is provided in the shaft forexpanding the inner balloon against the outer balloon to place thereceiving coil in close proximity to the area of interest in order toprovide MRI images.

Typically, the planning of radiation therapy for the treatment ofprostate cancer involves the patient undergoing a CT-based simulationscan of the pelvis to determine the location of the prostate gland. Inthe simulation phase, the patient is placed on CT equipment that ispreferably similar to the radiation treatment equipment (except that itdoes not generate the high energy radiation beam). The simulationequipment is positioned to simulate the delivery of the sequence oftreatment beams prescribed by the treating oncologist. Normally, duringthe simulation procedure, CT images are acquired. These CT images allowthe oncologist to locate the position of the tumor and help tofacilitate the composition of a radiation treatment plan. This treatmentplan delineates the positions of the radiation equipment components fordelivery of the treatment beams.

During the actual treatment phase, the patient is placed in the sameposition on the treatment equipment as in the simulation scans.Radiation-emitting devices are generally known and used for radiationtherapy in the treatment of patients. Typically, a radiation therapydevice includes a gantry, which can be swiveled around a horizontal axisof rotation in the course of a therapeutic treatment. A linearaccelerator is located in the gantry for generating a high-energyradiation beam for therapy. During treatment, the radiation beam isprovided by this equipment and is delivered to the patient at theprecise location as delineated by the physician during simulation. Afurther feature of radiation therapy involves portal images, which arecommonly used in radiation therapy to verify and record the patienttumor location. Portal images include manual (film) and electronicimages (EPI) taken before and/or after the treatment.

During external beam radiation therapy, radiation is directed to thetarget prostate, which is near the rectal wall. Typically, a pluralityof beams are used, and where the beams cross the highest radiation isprovided. A misdirected radiation beam may perforate the rectal wallcausing radiation proctitus (rectal bleeding). This toxicity is relatedto the total radiation dose prescribed and the volume of the anteriorrectal wall receiving a high radiation dose. A major factor limitingradiation oncologists' attempts to reduce the volume of the anteriorrectal wall receiving a high radiation dose is the position of theprostate gland as well as the intrinsic motion up to 5 mm in theanterior to posterior direction caused by rectal peristalsis.Accordingly, oncologists generally will add a margin to the radiationfield in order to ensure that the entire prostate gland receives theprescription dose. This margin is typically on the order of 5 to 15 mm.As a consequence, lower doses of radiation may need to be used so as notto overexpose radiation sensitive healthy structures. However, this maylead to inadequate radiation treatment and a higher probability of localcancer recurrence.

US20030028097 proposes an insertable probe for immobilizing a region ofinterest during staging and radiation therapy thereof. In particular, aballoon is proposed having a rectangular cross section connected to ashaft. The shaft extends to an end of the balloon so as to allow fluidflow through an interior of the shaft and into the balloon so as toselectively inflate the balloon once the balloon is installed into therectal cavity. The balloon, shaft and handle are bonded together so thatthey move radially as a single unit when torque is applied. A syringe isprovided which connects the shaft and serves as an air pump to deliver avolume-limited amount of air to the air lumen of the shaft to theballoon. A stop-cock is provided to maintain the air within the balloon.

One of the problems with the subject of US20030028097 is the discomfortassociated with installing the rectal balloon within the rectal cavity.In particular, a relatively sturdy and wide diameter shaft is connectedto a relatively large thick-walled balloon. Because the balloon is notsupported by anything other than by the shaft, the balloon is formed ofa relatively rugged and thick material. Because of the relatively largesize of the shaft and the thick material of the rectangular-crosssection balloon, the installation of the rectal balloon creates a largeamount of discomfort for a patient. In addition, it is often difficultfor the medical personnel to know exactly how far within the rectum theballoon has been installed. Thus, it is difficult to achieve astandardized and fixed position of the balloon during each and everyuse. The medical personnel must generally approximate the desiredposition of the balloon within the rectal cavity. As such, a need hasdeveloped whereby the rectal balloon can be formed of a minimal diametershaft and of a balloon of relatively thin material.

When the rectal balloon of US20030028097 is in an inflated condition,the outer surface is generally rounded. As such, the prostate will tendto balance on the curved (convex) surface rather than be properly seatedthereon. Since seating is important for proper use, this device requiresthat the physician approximate a seated position rather than providingany feedback of the seated position. When the balloon is in a curvedinflated condition, the prostate will have a tendency to slide to oneside of the balloon or the other. As such, a need developed to provide arectal balloon that retains the prostate in a properly seated positionwhen the balloon is in a fully inflated condition.

As discussed above, a very important consideration when treatingpatients using radiation therapy is that the proper dose of radiationreaches the treatment site. This is very important whether the treatmentmethod utilizes implanted radiation seeds or external beams ofradiation. Excessive dosing of the patient can lead to severe sideeffects including impotence and urinary incontinence. In fact, estimatesprovide that as many as half the patients treated suffer incontinenceand/or impotence. A proper treatment plan should deliver an adequateamount of radiation to the treatment site while minimizing the dosedelivered to the surrounding tissues, and thus minimizing these sideeffects.

U.S. Pat. No. 6,963,771 describes a method, system and implantabledevice for radiation dose verification. The method includes (a) placingat least one wireless implantable sensor in a first subject at a targetlocation; (b) administering a first dose of radiation therapy into thefirst subject; (c) obtaining radiation data from the at least onewireless implantable sensor; and (d) calculating a radiation dose amountreceived by the first subject at the target location based on theradiation data obtained from the at least one wireless sensor duringand/or after exposure to the first administered dose of radiation todetermine and/or verify a dose amount of radiation delivered to thetarget location.

U.S. Pat. No. 7,361,134 proposes a method of determining the dose rateof a radiation source including locating three or more detectors in thevicinity of a source. Each of the detectors provides an outputindicative of the amount of radiation received from the source anddetermines the location of the source from at least some of the detectoroutputs. International Pub. No. WO2008148150 proposes a semiconductorradiation sensor.

US20090236510 proposes a radiation dosimeter for measuring a relativedose of a predetermined radiation type within a detection region byusing a plurality of scintillating optical fibers. US20060094923proposes a marker comprising a wireless transponder configured towirelessly transmit a location signal in response to a wirelesslytransmitted excitation energy.

A significant cause of patient discomfort associated with rectalballoons of the prior art is the buildup of gas pressure when theballoon is inserted into the rectum. This buildup of gas pressure canalso affect the ability to properly seat the balloon in a desiredposition. Furthermore, gas buildup is now known to cause a significantamount of prostate movement. Therefore, a device that could eliminatesame would be of benefit in allowing margin reductions and thus fewerside effects.

A need exists for a rectal balloon apparatus that relieves rectal gaspressure prior to or during inflation of the balloon, as well as duringtreatment.

BRIEF SUMMARY OF THE DISCLOSURE

A rectal balloon apparatus comprises a shaft having a fluid passagewayextending therethrough. A lumen may be positioned with or be integral tothe shaft for movement of rectal gas or other rectal fluids. A flexibletip with one or more openings may be disposed on the end of the shaftand/or the rectal gas relieving lumen inserted into the rectum. Theshaft may have a locking device that is slidable longitudinally alongthe shaft. The locking device may be locked at a desired indicia on theshaft to fix the amount of movement of the shaft into the rectum. In oneembodiment, a splitting device disposed with the ends of the shaft andthe rectal gas relieving lumen that are not inserted into the rectum maysplit the lumen from the fluid passageway of the shaft. The lumen porton the splitting device may have a luer lock device for placement of alumen port cap to prevent the back flow of rectal fluids. A syringe maybe positioned with the luer lock to flush the lumen.

A balloon may be affixed over an end of the shaft such that the fluidpassageway communicates with an interior of the balloon. The balloon canbe converted from a non-inflated condition to an inflated condition. Aradiation detecting sensor may be positioned at any location with theballoon, the shaft, and/or the rectal gas relieving lumen for sensingthe amount of radiation delivered. A motion detecting sensor may bepositioned at any location with the balloon, the shaft, and/or therectal gas relieving lumen for sensing the amount of motion or movementof the balloon or surrounding area, such as the part of the rectal wallnear the prostate, the shaft, the rectal gas relieving lumen, theradiation sensor, any fiducial markers, and/or any other part of theapparatus. The balloon may have a generally laterally flat surface whenin the inflated condition, with a longitudinal groove formed in thelaterally flat surface. One or more fiducial markers may be positionedat any location with the balloon, the shaft, and/or the rectal gasrelieving lumen. A fiducial marker may be positioned with the flexibletip at the end of the shaft and/or lumen inserted into the rectum. Othertypes of sensors may be positioned with the balloon, the shaft and/orthe lumen. A processor may be used to interpret the information from thedifferent sensors and fiducial markers.

The invention includes one or more of the following embodiments in anycombinations thereof:

A method of treating prostate cancer by external beam radiation therapy(XRT), comprising: a) inserting a prostate immobilizing balloon into arectum of a patient with a cancerous prostate; said balloon comprising:i) a proximal end and a distal end; ii) a first lumen communicating withan interior of said balloon, said first lumen having a closable valve;iii) a second lumen extending from past said proximal end of saidballoon to past said distal end of said balloon, said second lumenhaving a capped distal tip and one or more ports adjacent said cappeddistal tip and distal to said balloon; iv) said balloon furthercomprising one or more fiducial markers on a surface thereof; b)allowing rectal gas to exit the rectum via said one or more ports untilno further exiting gas is evident; c) inflating said balloonsufficiently to compress and immobilize said prostate; d) determiningthe position of said one or more fiducial markers and positioning saidballoon such that said fiducial markers are in a desired position, e)treating said prostate with XRT; and f) allowing rectal gas to exit therectum via said one or more ports during said treatment.

A method of treating prostate cancer by XRT, comprising: a)inserting aprostate immobilizing balloon into a rectum of a patient with acancerous prostate; said balloon comprising: i) a proximal end and adistal end; ii) a first lumen communicating with an interior of saidballoon, said first lumen having a closable valve; iii) a second lumenextending from past said proximal end of said balloon to past saiddistal end of said balloon, said second lumen having a capped distal tipand one or more ports adjacent said capped distal tip and distal to saidballoon; b) allowing rectal gas to exit the rectum via said one or moreports until no further exiting gas is evident; c) inflating said balloonsufficiently to immobilize said prostate; d) treating said prostate withXRT; and e) allowing rectal gas to exit the rectum via said one or moreports during said treatment.

A method of treating prostate cancer, said method comprising: a)inserting a prostate immobilizing balloon into the rectum of a patient;i) said balloon being shaped and sized to immobilize a prostate wheninflated; ii) said balloon further comprising a gas releasing fluidpassageway extending from beyond a distal end of said balloon to beyonda proximal ends of said balloon, said passageway having a closed distaltip and one or more ports distal to said balloon; b) allowing rectal gasto exit the rectum via said one or more ports; c) inflating said balloonsufficiently to compress and immobilize said prostate; d) treating saidprostate plus a margin of surrounding tissue with XRT; e) wherein saidmargin is smaller than it would be with a comparable balloon lackingsaid gas releasing fluid passageway.

A method of treating prostate cancer, said method comprising: a)inserting a prostate immobilizing balloon into the rectum of a patient;i) said balloon being shaped and sized to immobilize a prostate wheninflated; ii) said balloon further comprising a gas releasing fluidpassageway extending from beyond a distal end of said balloon to beyonda proximal ends of said balloon, said passageway having a closed distaltip and one or more ports distal to said balloon; b) allowing rectal gasto exit the rectum via said one or more ports; c) inflating said balloonsufficiently to compress and immobilize said prostate; d) treating saidprostate plus a margin of surrounding tissue with a dose of XRT; e)wherein a dosage of XRT to said margin is smaller than it would be witha comparable balloon lacking said gas releasing fluid passageway.

A method wherein said balloon further comprises one or more fiducialmarkers, and said method further comprises determining the position ofsaid one or more fiducial markers and positioning said balloon such thatsaid fiducial markers are in a desired position.

A method wherein said balloon further comprises a locking device on saidfirst lumen, and said method further comprising reproducibly positioningand locking said locking device on said first lumen.

A method wherein said balloon further comprises a radiation sensorthereon, said method further comprising measuring a dosage of said XRTwith said radiation sensor and stopping said XRT when said measureddosage reaches a desired dosage amount.

BRIEF DESCRIPTION OF THE DRAWINGS

A better understanding of the present disclosure can be obtained withthe following detailed descriptions of the various disclosed embodimentsin the drawings:

FIG. 1 is a side elevational view showing a rectal balloon apparatus inan uninflated condition.

FIG. 2 is a side elevational view of a rectal balloon apparatus in aninflated condition.

FIG. 3 is an isolated view showing the compact folding of the balloonover the end of the shaft.

FIG. 4 is a top view of an inflated balloon showing the application offiducial markers, radiation detecting sensors, and motion detectingsensors.

FIG. 5 is a side view, partially transparent, of a balloon in a firstinflated condition.

FIG. 6 is a side view, partially transparent, of a balloon in a secondinflated condition.

FIG. 7 is a side view of a locking device in the locked position withthe rectal balloon apparatus positioned within the anal canal.

FIG. 7A is a perspective isolated view of the locking device in theunlocked position.

FIG. 8 is side view of the balloon of the rectal balloon apparatuspositioned within the rectum and in an inflated condition.

FIG. 9 is side view of the balloon in an inflated condition with arectal gas relieving lumen integral with a shaft, and radiationdetecting sensors and motion detecting sensors positioned with theballoon.

FIG. 10 is side view, partially transparent, of a balloon in theinflated condition with a rectal gas relieving lumen integral with ashaft, and radiation detecting sensors and motion detecting sensorspositioned with the balloon.

FIG. 11 is side view of a balloon in the inflated condition with arectal gas relieving lumen inside the fluid passageway of a shaft, asplitting device, and a lumen port cap positioned with the lumen port ofthe splitting device.

FIG. 12 is an enlarged view of the balloon of FIG. 11.

FIG. 13 is an enlarged view of the splitting device of FIG. 11 showingthe lumen port cap disposed with a luer lock.

FIG. 14A Mean frequency of rectal gas according to region and type ofERB used. The mean incidences of gas in one or more regions and in theanterior region differed at statistically significant levels (p<0.00001and p<0.0000001, respectively) between the standard and gas-releaseERBs. Error bars represent the standard deviation of the mean of withinpatient means.

FIG. 14B: size of gas pockets. From Wootton 2012.

FIG. 15 perspective of a gas release balloon cut about half way showingexterior lumen having holes along its length, thus allowing the releaseof gas trapped along the balloon.

DETAILED DESCRIPTION

FIG. 1 shows a rectal balloon apparatus 10 comprising a shaft 12 havinga fluid passageway extending therethrough. A balloon 14 is affixed overthe end 16 of the shaft 12. The balloon 14 is shown in an uninflated ordeflated condition. The fluid passageway of the shaft 12 can communicatewith the interior of the balloon 14. Also shown is the locking device13, which is shown in more detail in FIGS. 7 and 7A and discussed belowin detail therewith. The locking device 13 serves to assurereproducibility in the positioning of the balloon 14 during radiationtherapy.

The shaft 12 may be a generally longitudinal shaft, which has the fluidpassageway extending through the center thereof. As used herein, fluidmay mean gas, such as air, or liquid, such as water or saline. The shaft12 is preferably made of a flexible material. A valve assembly 22 may beaffixed to the shaft 12 opposite the balloon 14. The valve assembly 22can have a variety of configurations. FIG. 1 illustrates the valveassembly 22 as an inline valve assembly configuration. The valveassembly 22 may also be an angled valve assembly configuration. Thevalve assembly 22 includes a stopcock 26. A valve 28 facilitates theability of the stopcock 26 to open and close so as to selectively allowthe fluid to pass into the shaft 12. A port 30 allows the valve assembly22 to be connected to a supply of the fluid. When the stopcock 26 isopened by the rotation of the valve 28, the fluid will flow through thevalve assembly 22, through the interior passageway of the shaft 12 andinto the interior of the balloon 14. The valve 28 can then be closed soas to maintain the inflated configuration of the balloon 14. When theprocedure is finished and the fluid needs to be removed from the balloon14, the valve 28 of stopcock 26 can then be opened so as to allow forthe release of fluid therethrough.

The opposite end 16 of the shaft 12 may contact the end 32 of theballoon 14. The end 16 may be suitably curved (rounded or dome-shaped)so as to allow the shaft 12 to facilitate the introduction of theballoon 14 into the rectal cavity. The shaft 12 may have indicia 34formed therealong. It can be seen that the indicia 34 has numericalreferences associated therewith. These numerical references areindicative of the distance that the balloon 14 has been inserted intothe rectum. As such, the indicia 34 provide a clear indication to themedical personnel of the desired location of the rectal balloon 14. Ananal dilator ring 19 is shown adjacent an end of the balloon 14.

FIG. 2 illustrates an isolated view of the apparatus 10 after beinginstalled within the rectum. The fluid can be introduced through thevalve assembly 22 and through the interior passageway of the shaft 12 soas to inflate the balloon 14. The balloon 14 may have a seating area 15so that the prostate can be properly positioned thereon. When theballoon 14 is installed and inflated (˜100 cc), the prostate may resideon the flat surface 15 in a seated position. After the procedure hasbeen completed, the balloon 14 can be deflated and easily pulledoutwardly of the rectum in its deflated condition. In FIG. 2, it can beseen that the locking device 13 has been moved along the shaft 12 (fromits position in FIG. 1) to indicia 34, specifically at the number “20.”This serves to assure that the balloon 14 will be in a proper positionduring subsequent radiation treatments.

FIG. 3 shows that the balloon 14 is neatly folded and compressed overthe outer diameter of the shaft 12. The shaft 12 may have a rounded endabutting the end 32 of the balloon 14. As such, a comfortable roundedprofile may be provided at this end 32. The balloon 14 may bepre-vacuumed during production to produce a minimal profile during use.The anal dilator ring 19 is placed over the shaft 12.

FIG. 4 is a top view of the balloon 14 showing the area of the balloon14 that preferably engages with the prostate. Central seating area 46for the prostate is shown as having a groove 52 formed thereon. Thegroove 52 may be generally rectangular-shaped and may engage with thetip of the prostate, reducing lateral motion. Other configurations ofthe groove 52 are contemplated. The central seating area 46 and thegroove 52 enhance the holding stability of the balloon 14. The headportion 17 of the balloon 14 may be generally tapered. This shape makesinsertion of the balloon 14 into the rectum easier for medical personneland more comfortable for the patient. The balloon 14 may have athermally welded bond 53 connecting it to the shaft 12. Other forms ofbonding are also contemplated.

A first radiation detecting sensor 70 may be located within the groove52 of the central seating area 46. The sensor 70 allows the treatingphysician to determine the real time delivery dose of radiation beingreceived at the treatment area when the balloon 14 is in place. Thesensor 70 may located in the middle of the groove 52. This location isideally centrally located on the prostate when the balloon 14 is inplace. However, the radiation detecting sensor 70 may be positioned atany other location with the balloon, the shaft, or a rectal gasrelieving lumen (not shown). A second radiation detecting sensor 70B isshown disposed with the shaft, and a third radiation detecting sensor70A is shown positioned with the balloon surface. A radiation detectingsensor may be positioned with any surface of the balloon, the shaft, ora rectal gas relieving lumen. It is also contemplated that a radiationdetecting sensor may be positioned unattached in the interior of theballoon.

As shown in FIG. 5, a fourth radiation detecting sensor 70C ispositioned on the curved surface 44 of the balloon that is not adjacentthe treatment area. Although only one radiation detecting sensor ispreferably used, it is contemplated that more than one radiation sensor70, 70A, 70B, 70C may be used. By positioning the sensor(s) 70, 70A,70B, 70C near or adjacent to the prostate or other targeted anatomies,an accurate measurement of the radiation delivered to the prostateand/or other targeted anatomies, such as seminal vesicles, may beachieved. The sensors 70, 70A, 70B, 70C can be chosen from any of theavailable sensors that enable the user to monitor radiation dosage.International Pub No. WO 2008/148150 proposes the preferable type ofsemiconductor radiation sensor that is contemplated. U.S. Pat. No.7,361,134 also proposes a type of radiation sensor that is contemplated.It is also contemplated that a radiation sensor using scintillatingfiber optics may be used. The sensor 70, 70A, 70B, 70C may be positionedwith the balloon, the shaft, or the gas relieving lumen with anadhesive, such as an epoxy glue. However, other attachment means arecontemplated as are known in the art.

Six fiducial markers 72 are shown positioned with the balloon 14.Although a plurality of markers 72 are shown, it is contemplated thatthere may be only one or more fiducial markers 72. It is contemplatedthat one or more fiducial markers 72A may be positioned anywhere withthe balloon, the shaft, or the gas relieving lumen (not shown). Afiducial marker 72A is shown positioned at the very end of the shaft.The fiducial markers 72, 72A may be made of a tungsten material, whichmay be detected by an MRI or CT scan. Other materials that may bevisible on an MRI or CT scan are also contemplated, such as bariumsulfate. Fiducial markers in powder or liquid form are contemplated.Through the use of these fiducial markers 72, 72A on the balloon 14 orshaft 12, a treating physician may get a clear image of the position ofanterior and posterior walls of the rectum, and/or the position of therectum relative to the prostate. Fiducial markers 72 may be positionedin spaced relation to each other with the top surface of the balloon 14.For illustrative purposes, three of the fiducial markers 72 arepositioned in linear alignment on one side of the groove 52. Anotherthree fiducial markers 72 are arranged on the opposite side of thegroove 52. Other combinations and locations of markers 72, 72A arecontemplated. A further benefit can be realized by utilizing anadditional fiducial marker in the form of a gold seed marker implantedinto the prostate. The gold seed marker combined with the fiducialmarkers 72 allows for triangulation to make certain that the balloon,rectum, and prostate are in the correct positions for treatment.

A first motion detecting sensor 73 is shown within the groove 52 of thecentral seating area 46. The motion detecting sensor 73 allows thetreating physician to determine the movement of any of the radiationsensors 70, 70A, 70B, 70C, fiducial markers 72, 72A, the shaft, the gasrelieving lumen, the balloon surface and the surrounding area, such asthe part of the rectal wall near the prostate, and/or any other part ofthe apparatus. Although the motion detecting sensor 73 is shown in thegroove 52, one or more motion detecting sensors 73 may be positioned atany other location with the balloon, the shaft, or the gas relievinglumen (not shown). A second motion detecting sensor 73A is shown placedat a different location with the surface the balloon. As shown in FIG.5, a third motion detecting sensor 73B may be positioned with the curvedsurface of the balloon that is not adjacent the treatment area. Althoughonly one motion detecting sensor is preferably used, it is contemplatedthat more than one motion detecting sensor 73, 73A, 73B may be used. Themotion detecting sensors 73, 73A, 73B may be selected from any of theavailable sensors that enable the user to detect motion. It iscontemplated that disposable sensors may be used. It is alsocontemplated that an electromagnetic type motion detecting sensor may beused. Other types of sensors are contemplated.

FIG. 5 is an isolated view of the balloon 14 as inflated to a firstinflated condition. In this condition, the balloon 14 has a centralseating portion 46, a head portion 17 and a posterior portion 44. Wheninflated, the central seating area 46 has a lateral flatness for theprostate to rest upon. The lateral flatness of the seating area 46 willprevent the prostate from sliding to one side or the other, and notdeform the prostate. The bottom portion 44 is rounded and contacts therectal wall. The head portion 17 is generally tapered so as tofacilitate easier insertion of the balloon 14. The material of theballoon 14 may be formed of a non-latex material, such as medical gradepolyurethane, so as to avoid allergic reactions. The shaft 12 is shownextending into the interior of the balloon 14. A plurality of holes 48may be formed in the shaft 12 through which the balloon 14 is filledwith air or other fluid.

For all embodiments shown in all Figures, the balloons, such as balloon14 in FIG. 5, may have a posterior or bottom portion, such as bottomportion 44, that is made from a different thickness film material thanthe seating portion, such as seating portion 46. By way of example, theposterior (bottom) portion 44 may be made with a thicker material thanthe seating (top) portion 46. The thicker material may allow a supportstructure for the balloon 14, and the thinner material may allow for theseating portion 46 to maintain its shape or have a distal bulge, such asbulge 47 shown in FIG. 6. It is also contemplated that the posteriorportion 44 may be thinner than the seating portion 46. The balloon maybe made from two or more materials with different thicknesses attachedtogether, such as by thermally welded bond. It is also contemplated thatthe balloon may be made from two or more materials with the samethickness but with different elasticity properties, such as differentmodulus of elasticity.

It can be seem that each of the holes 48 is spaced from and offset by90° from an adjacent hole around the diameter of shaft 12. Otherarrangements and orientations are contemplated. A total of six holes maypreferably be formed in the shaft 12 within balloon 14 so as to allowthe fluid to pass from an interior of shaft 12 to the interior of theballoon 14. Other numbers of holes are contemplated. This arrangement ofholes 48 facilitates complete extraction of the fluid from the balloon14. Under certain circumstances, one of the holes may become clogged orblocked by contact between the body and the balloon, and the stagedarrangement assures that the unblocked holes 48 allow the fluid tocontinues to be easily extracted. In FIG. 5, it can be seen thatadditional fiducial markers 72 are positioned on the opposite side ofballoon 14.

FIG. 6 is an isolated view of the balloon 14 as inflated to a second,more inflated condition (˜120 cc). In the second inflated condition, theballoon 14 has a first bulge 47 formed at the head portion 17. Theballoon also has a laterally flat seating portion 46. The distal bulge47 can be utilized in certain conditions to better isolate the prostateand stabilize the seminal vesicles.

Turning to FIG. 7, the prostate immobilizer 10 has a shaft 12 having afluid passageway 64 extending therethrough, a balloon 14 extending overan end 16 of the shaft 12 such that the fluid passageway 64 communicateswith an interior 66 of the balloon 14, a rectal gas relieving lumen 60extending within the shaft 12 so as have an end 62 opening adjacent anend 68 of the balloon 14, and a locking device 13 for locking a positionof the shaft 12 of the prostate immobilizer 10. The device 13 isadjustably slidable along the shaft 12. The device 13 serves to assureuniformity in the positioning of the balloon 14 in the rectal cavity 2adjacent the prostate 3 during radiation therapy.

The end 16 of the shaft 12 is adjacent the end 68 of the balloon 14. Theend 16 of the shaft 12 is suitably rounded so as to allow the shaft 12to facilitate the introduction of the balloon 14 into the rectal cavity2. The prostate immobilizer 10 is inserted into the rectal cavity 2through anus 1. The shaft indicia 34 has numerical references associatedtherewith. The numerical references are indicative of the distance thatthe balloon 14 is inserted into the anus 1. The indicia 34 provide aclear indication to medical personnel of the position of the balloon 14in the rectal cavity 2 for repeatability for subsequent treatments. Theballoon 14 can be removed and re-inserted into the rectal cavity 2. Thelocking device 13 is affixed to the shaft 12 so that the balloon 14 willbe repositioned for a same distance into the rectal cavity 2 adjacentthe prostate 3.

The locking device 13 is shown as positioned where indicia 34 number“25”. The anal dilator ring 19 is affixed to the shaft 12 adjacent theballoon 14. The anal dilator ring 19 may displace the anal verge so asto displace the anal tissue and delineate the anatomy. The anal dilatorring 19 has a diameter greater than a diameter of the shaft 12.

Once the balloon 14 is positioned in a desired location adjacent theprostate 3, medical personnel position the locking device 13 so that itis adjacent the anus 1 and holds the prostate immobilizer 10 inposition. The balloon 14 is shown in an inflated condition. The seatingarea 15 is positioned adjacent the prostate 3 when in the rectal cavity2. The prostate immobilizer 10 is inserted and removed from the anus 1in the deflated condition. The lateral flatness of the seating area 15resists and inhibits the prostate 3 motion. The rounded outer surface ofthe balloon 14 generally contacts the wall of the rectal cavity 2. Theballoon 14 can be formed of a non-latex material, such as polyurethane,so as to avoid allergic reactions.

The gas relieving lumen 60, although shown on the interior of the shaft12, can be in any other orientation, such as on the outer surface of theshaft 12, that allows for the removal of rectal gas, but preferably isintegral with or immediately adjacent the fluid filling shaft. End 62 ofthe lumen 60 has one or more openings that allow for rectal gas or otherbodily fluids to escape from the rectal cavity 2 and out of the lumen60. A one-way valve can be included along the length of the lumen 60 soas to only allow rectal gas or other bodily fluids to pass from therectal cavity 2 to the outside environment through the gas relievinglumen 60. The interior of the shaft 12 may be in fluid communicationwith the interior 66 of the balloon 14 so as to allow fluids to passinto and out of the interior 66 of the balloon 14 for inflation anddeflation.

During subsequent radiation treatments, the locking device 13 can beaffixed to the shaft 12 in the same position as shown in FIG. 7. Assuch, when the balloon 14 is inserted, the shaft 12 can be urged forwarduntil the locking device 13 contacts the entrance of the anus. Themedical personnel may thus be confident that the balloon 14 is in theproper position. This is accomplished accurately regardless of anychange of medical personnel, any squeezing of the sphincter muscles bythe patient, and any variations in the amount of lubrication jelly thatis used. Repeatability is typically assured. Reproducibility isparticularly important when a radiation sensor is used in conjunctionwith the balloon. It is desirable that the radiation detecting sensor bein the substantially same location each time that it is detectingradiation. When the locking device is affixed to the shaft, it will notbe easily displaced. The smooth contour of the outer surface contactingthe anus provides comfort to the patient.

In FIG. 7A, the locking device 13 is in an unlocked position prior toattaching to the shaft 12 (not shown). The device 13 has a positioningmember 18 and a locking member 38. The positioning member 18 has a headportion 20 and a stem portion 320. The stem portion 320 is integrallyformed adjacent an end 24 of the head portion 20. The positioning member18 has a channel 340 formed therein. The channel 340 extends througheach of the head portion 20 and the stem portion 320. The positioningmember 18 has a longitudinal split 36 formed therein. The longitudinalsplit 36 extends through the head portion 20. The longitudinal split 36communicates with the channel 340. The locking member 38 has a lockedposition and an unlocked position. The locking member 38 is hingedlyconnected to the stem portion 320 of the positioning member 18. The headportion 20 of the positioning member 18 has a hemispherical shape. Thestem portion 320 of the positioning member 18 has an outer surface flushwith an outer surface of the head portion 20. The longitudinal split 36extends for the entire length of the head portion 20. The longitudinalsplit 36 has a width slightly greater than the diameter of the shaft 12.This allows the shaft 12 to be introduced into the channel 340.

The stem portion 320 has an outer surface 40 that is flush with an outersurface of the head portion 20. As such, the locking device 13 hassmooth contours on the outer surface thereof. The stem portion 320 has alip 480 extending and angling upwardly and outwardly of the outersurface 40. The lip 480 is generally adjacent to the wall of thelongitudinal split 36 of the head portion 20. A curved surface 470 isformed on the interior of the stem portion 320 and has a plurality ofribs formed thereon. The curved surface 470 devices a portion of thechannel 340. The longitudinally-extending ribs on the curved surface 470of channel 340 provide a structure that can suitably grip the outersurface of the shaft so as to facilitate the ability to fix the positionof the locking device 13 on shaft 12. Alternatively, the interior can besmooth but made of a tacky material that grips the shaft and/or lumen.

The locking member 38 is hingedly connected to the stem portion 320. Thelocking member 50 includes a latch 50 that has an edge that will engagethe lip 480 of the stem portion 320. The inner surface 51 of the lockingmember 50 includes a curved area 53. Curved area 53 has ribs to grip andgenerally corresponds with the location of the curved surface 470 ofstem portion 320. As such, curved area 53 will cooperate with the curvedsurface 470 so as to define the channel 340 of the positioning member 18when the locking member 38 is in a locked position. The locking member38 also has an inner surface 52 which will reside in proximity with theend 24 of the head portion 20.

FIG. 8 shows an anatomical side view of the rectal balloon apparatus 10positioned within a patient's rectum, as it would be during use. Theballoon 14 is shown in an inflated condition and positioned up againstand between the anterior wall 92 and the posterior wall 94 of the rectum96. It can be seen that the balloon 14 is positioned adjacent theprostate 90, and that the balloon has been inflated enough to expand therectum significantly. The fully inflated balloon thus compresses theprostate, tending to immobilize it in position adjacent the inflatedballoon, and this reduction in motion allows the treating physician toreduce the treatment margins, thus irradiating less healthy tissue.Further, we now have clinical evidence, that the gas releasing lumen,which allows gas to escape during treatment, even further reduces themobility of the prostate over a similar balloon lacking the gas releasefeature, allowing a further reduction in treatment margins.

Additionally, it can be seen that a radiation detecting sensor 70 and amotion detecting sensor 73 are generally positioned adjacent theanterior wall 92 of the rectum 96. It is also contemplated that aplurality of fiducial markers may also be positioned adjacent theanterior wall and/or the posterior wall 94 of the rectum 96, and theballoon position adjusted as needed to ensure reproducible positioningas determined by visualizing the location of the fiducial markers. Thus,when a treating physician can determine the position of the plurality offiducial markers he or she may obtain a clear image of the contours ofthe anterior wall 92 and the posterior wall 94 of the rectum 96 byessentially “connecting the dots.” The radiation sensor 70 may be usedto detect the amount of radiation being received by the target areas,such as the rectal-prostate interface. The motion detecting sensor 73may detect the movement of any of the sensors, markers, balloon surfaceor surrounding area, balloon shaft, or other part of the apparatus,allowing the balloon to be repositioned if needed. FIG. 8 also shows theimportance of the flexible aspect of the shaft 12 (which allows thetechnician to move the shaft as needed for filling etc. withoutinadvertently changing the position of the balloon) and the utilizationof the locking device 13. The locking device 13 and numerical indiciaprovides an initial indication of the depth of positioning of theballoon 14. Thus, the device can be inserted to the same depth withevery treatment, and then locked in place against further ingress. Thelateral flatness of the balloon 14 is thereby assuredly positionedadjacent the prostate.

The radiation detecting sensor 70 is thereby attempted to be positionedat the same location during all treatments. The sensor 70 can then beused to determine the amount of radiation delivered during eachtreatment, both daily radiation doses and accumulative radiation for thecourse of treatment. Treatment is of course halted when the properradiation level or dosage has been reached.

FIG. 9 is a side view of a rectal balloon apparatus 110 having a balloon114 with a rectal gas relieving lumen 116 positioned with a surface ofthe shaft 112. The gas release lumen 116 extends to an exterior of theballoon 114. First opening 118 allows rectal gas or other fluids to passfrom an exterior of the balloon 114 into the lumen 116. The rectal gaspasses through the lumen 116 to another opening at the opposite end ofthe lumen 116, and into the atmosphere. The lumen 116 will have aportion extending interior of the balloon 114. The ends of the balloon114 will be sealed around the lumen 116 and the shaft 112. A flexiblelumen tip with ports (or holes), like lumen tip 156 shown in FIG. 12,may be positioned over first opening 118. The flexible lumen tip withports may provide for patient comfort when the shaft 112 is insertedinto the rectum, and also serve to minimize fecal material from enteringand clogging or obstructing the gas release lumen 116.

A first radiation detecting sensor 140 may be located with the balloon114. The sensor 140 is preferably located adjacent the prostate when theballoon 114 is in place. However, the radiation detecting sensor 140 maybe positioned at any other location with the balloon 114, the shaft 112,or the lumen 116, including the flexible lumen tip, such as tip 156 inFIG. 12. A second radiation detecting sensor 140A is shown disposed withthe shaft, and a third radiation detecting sensor 140B is shownpositioned with the lumen. It is also contemplated that a radiationdetecting sensor may be positioned unattached in the interior of theballoon. As shown in FIG. 10, a fourth radiation detecting sensor 140Cmay be positioned on the surface of the balloon that is not adjacent thetreatment area. International Pub No. WO 2008/148150 proposes a type ofsemiconductor radiation sensor that is contemplated. U.S. Pat. No.7,361,134 also proposes a type of radiation sensor that is contemplated.It is also contemplated that a radiation sensor using scintillatingfiber optics may be used. Although only one radiation detecting sensoris preferably used, it is contemplated that more than one radiationsensor 140, 140A, 140B, 140C may be used.

Six fiducial markers 142 are shown positioned with the balloon 114.Although a plurality of markers 142 are shown, it is contemplated thatthere may be only one or yen more fiducial markers 142. It iscontemplated that one or more fiducial markers 142 may be positionedanywhere with the balloon 114, the shaft 112, or the lumen 116,including a lumen tip with ports. A fiducial marker 142A is shownpositioned at the end of the shaft 112. The fiducial markers 142, 142Amay be made of a tungsten material, which may be detected by an MRI orCT scan. Other materials that may be visible on an MRI or CT scan arealso contemplated, such as barium sulfate. Fiducial markers in powder orliquid form are contemplated. Other combinations and locations ofmarkers 142, 142A are contemplated.

A first motion detecting sensor 143 is shown positioned with the balloon114. The motion detecting sensor 143 allows the treating physician todetermine the movement of the any of the radiation detecting sensors140, 140A, 140B, 140C, fiducial markers 142, 142A, balloon shaft 112,lumen 116, or the balloon 114 and the surrounding area, such as the partof the rectal wall near the prostate. One or more motion detectingsensors 143 may be positioned at any location with the balloon, theshaft, or the lumen. A second motion detecting sensor 143A is shownplaced at a different location with the surface the balloon. The motiondetecting sensors 143, 143A may be selected from any of the availablesensors that enable the user to detect motion.

FIG. 10 is a side view of a rectal balloon apparatus 120 having aballoon 124 with the gas pressure relieving activity of the rectal gasrelease lumen 126 integrated with the shaft 122. The shaft 122 extendsto an exterior of the balloon 124, and has an opening 128 outside of theballoon 124. A one-way valve means 130 may be formed within the shaft122. The one-way valve means 130 allows rectal gas to pass from theexterior of the balloon 124, into the opening 128, and through theone-way valve means 130 into the shaft 122. The one-way valve means 130prevents fluid or rectal gas from escaping through opening 128 from theinterior of the shaft 122 when closed, but when open, the one-way valvemeans 130 operates to allow bodily gas to escape through the interior ofthe shaft 122 when the balloon 124 is installed in the rectum. Air orother fluid may be introduced into the balloon 124 so as to inflate theballoon 124, while at the same time, closing the one-way valve means130, thus introducing fluid only to the balloon and not to the patient,and thereafter opened again. It is also contemplated that there may beno one-way valve means, and gas freely escapes via a completely separateair passageway throughout the treatment period. A flexible lumen tipwith ports, like tip 156 in FIG. 12, may be positioned over opening 128.The tip shown is closed, and the ports are adjacent thereto, but stilldistal to the balloon structure. The flexible tip or cap with ports mayprovide for patient comfort when the shaft 122 is inserted into therectum, and the closed tip prevents or minimizes bodily material fromentering the shaft 122. Radiation detecting sensors 140, 140A, 140B,140C, fiducial markers 142, 142A, and motion detecting sensors 143, 143Amay be positioned with the shaft 122 and/or the balloon 124 of FIG. 10as shown in FIG. 9. A sensor and/or fiducial marker may be positionedwith a flexible tip with ports positioned over first opening 118 oflumen 116.

FIG. 11 shows a balloon 154 positioned with shaft 162 having a fluidpassageway for inflating and deflating the balloon 154, and the lumen152 (best shown in FIG. 12) for allowing gas pressure to escape frombeyond the end of the balloon. The shaft 162 has ports in the area ofthe balloon for inflation and deflation, such as previously described. Aflexible tip or closed cap 156 is positioned on the end of the lumen152. Rectal gas may enter the port 168 adjacent the cap 156, and flowthrough the lumen 152, escaping through the lumen port 150 on thesplitting device 158. One or more lumen tip ports 168 are contemplated.As shown in greater detail in FIG. 13, the splitting means 158 splitsthe lumen 152 from the fluid passageway of the shaft 162. Returning toFIG. 11, anal dilator or collar 164 may be constructed of a hardmaterial and locked over the shaft 162. The collar 164 may have a hingeand a locking mechanism. Valve assembly 170 includes a control knob 172.Turning the control knob 172 serves to close the valve assembly 170 soas to selectively allow the fluid to pass into the shaft 162. A port 174allows the valve assembly to be connected to a supply of the fluid.

Turning to FIG. 12, radiation detecting sensors 140, 140A, 140B, 140C,fiducial markers 142, 142A, and motion detecting sensors 143, 143A maybe positioned with the shaft 162 and/or the balloon 154 similarly asshown in FIG. 9. A sensor and/or fiducial marker may be positioned withflexible lumen tip 156.

In FIG. 13, the lumen port 150 on the splitting device 158 may have alip formation 182 for placement of a lumen port cap 180. A luer lockformation or device is contemplated. It is contemplated that the cap 180may be threadingly attached with the lumen port 150. Other attachmentmeans as are known in the art are contemplated. The cap advantageouslyprevents fluid from escaping the lumen 152.

A retrospective study was performed comparing to quantify the effects anERB with a passive gas release conduit had on the incidence of rectalgas (Wootton 2012). Fifteen patients who were treated with a standardERB and with a gas-release ERB (both from RadiaDyne) were selected andlocation and cross-sectional area of gas pockets and the fraction oftime they occurred on lateral kilovoltage (kV) images were analyzed. Gaslocations were classified as trapped between the ERB and anterior rectalwall, between the ERB and posterior rectal wall, or superior to the ERB,e.g towards the sigmoidal colon. The results, shown in FIGS. 14A and Bshow that the gas-release ERB significantly decreased the number offractions in which gas was present, primarily by decreasing theincidence of gas trapped between the rectal balloon and the anteriorrectal wall. Therefore, the study recommended that gas-release ERBs beused in patients undergoing radiation therapy for prostate cancer.

Another study by Su found that compared to non-gas release balloons, gasrelease balloon reduced the magnitude of intrafractional prostate motionin both AP and SI directions. Thus, it allowed smaller treatment margins(Su 2012).

The prevalence of gas found in the anterior region is consistent withprevious findings and knowing that gas is most likely to be trapped inthe anterior region is important because gas trapped there will not onlydisplace the prostate, but also push the anterior rectal wall into thetreatment field. This could potentially alter the prostate and rectaldose distribution and possibly the treatment outcome.

In X-ray conformal or intensity-modulated radiation therapy, such achange in dose distribution would likely be small, and the negativeeffects of gas would stem mostly from organ displacement. However, inproton radiation therapy, gas in the treatment field can escalate doseto normal tissue to an unacceptably high level because of the extremesensitivity of protons to the medium they travel through. A protonbeam's range, and thus energy deposition, is extremely sensitive to thedensity of the medium through which the beam passes. Gas in theposterior and sigmoid regions can also displace the prostate, but thisoccurrence was not common when using either model of ERB in ouranalysis.

The cross-sectional areas of gas pockets did not change significantlywith respect to ERB model used demonstrating that, although gas occursless often with the gas-release balloon, the severity of the gas is notdecreased by it. A possible explanation for this result could be hastygas-release ERB insertion that does not allow time for gas to escapethrough the conduit before being trapped when the balloon is inflated.

If this is the case, the gas-release ERB could be used to betteradvantage by slow, careful insertion, giving the gas time to escapeduring all points of the insertion. Thus, inflation would not beginuntil the technician was reasonably sure that sufficient time wasallowed for all gas to escape. Alternatively, additional gas releasinglumens can be glued to the exterior of the balloon, especially on theanterior side which sits adjacent the prostate, with holes there alongto allow anterior gas pockets to escape.

This shown in FIG. 15, a cross sectioned half of a gas release balloonhaving an exterior mounted gas release lumen. The balloon is made ofbottom layer 1501 welded 1503 to top layer 1501 around the edges. Ifdesired, this balloon can be shaped as described above, but such detailsare omitted from this figure for the sake of clarity. An optionalcentral lumen is bifurcated at this point, providing a gas releasepassageway 1507, as well as a balloon filling passageway 1509 thatallows air to enter the balloon. Exterior gas release lumen 1511 ismounted to the outer layer of the balloon, e.g., by gluing or otherwelding process, and that lumen 1511 has openings 1513 along its lengthfor allowing the escape of gas pockets trapped alongside the balloon.The posterior of the balloon can also be equipped with a similar lumen1515, but this is optional, as gas on this side of the balloon maypresent less of a problem due to the distance from the prostate. Centrallumen 1507/1509 is optional in this embodiment, although shown herein,because the exterior lumen can serve the insertion function and can beprovided with closed distal tip and ports.

An important advantage of passive gas release over catheterization isthat it continues to work during patient treatment. Although existingrectal gas may be removed by a catheter at the beginning of treatment,gas may continue to build up during the course of the treatment, andthis occurance has been documented. The passive gas release balloondescribed herein alleviates build of gas upstream of the balloon, and ifprovided with an exterior gas release passageway mounted on an exteriorsurface of the balloon, even gas trapped alongside the balloon can beassured of release.

The foregoing disclosure and description of the invention areillustrative and explanatory thereof, and various changes in the detailsof the illustrated apparatus and system, and the construction and methodof operation may be made without departing from the spirit of theinvention.

The following are incorporated by reference herein in their entiretiesfor all purposes.

Wootton et al., Effectiveness of a novel gas-release endorectal balloonin the removal of rectal gas for prostate proton radiation therapy J.APPL. CLIN. MED. PHYS. 13(5): 190-197 (2012).

Su, et al., Abstract 3192 Reduction of Prostate Intrafraction Motionusing Gas-release Rectal Balloons, I. J. RadiationOncology*Biology*Physics 81(2) (S. 2011).

Su et al., Reduction of prostate intrafraction motion using gas-releaserectal balloons, 5869 Med. Phys. 39 (10): 5869 (2012).

U.S. Pat. No. 3,509,884; U.S. Pat. No. 4,813,429; US20030028097;US20060094923; US20070058778; US20090236510; U.S. Pat. No. 5,476,095;U.S. Pat. No. 6,963,771; U.S. Pat. No. 7,361,134; U.S. Pat. No.8,500,771; WO1994023676

I claim:
 1. A method of treating prostate cancer by external beamradiation therapy (XRT), comprising: a) inserting a prostateimmobilizing balloon into a rectum of a patient with a cancerousprostate; said balloon comprising: i) a proximal end and a distal end;ii) a first lumen communicating with an interior of said balloon, saidfirst lumen having a closable valve; iii) a second lumen extending frompast said proximal end of said balloon to past said distal end of saidballoon, said second lumen having a capped distal tip and one or moreports adjacent said capped distal tip and distal to said balloon; iv)said balloon further comprising one or more fiducial markers on asurface thereof; b) allowing rectal gas to exit the rectum via said oneor more ports until no further exiting gas is evident; c) inflating saidballoon sufficiently to compress and immobilize said prostate; d)determining the position of said one or more fiducial markers andpositioning said balloon such that said fiducial markers are in adesired position. e) treating said prostate with XRT; and f) allowingrectal gas to exit the rectum via said one or more ports during saidtreatment.
 2. A method of treating prostate cancer by XRT, comprising:a) inserting a prostate immobilizing balloon into a rectum of a patientwith a cancerous prostate; said balloon comprising: i) a proximal endand a distal end; ii) a first lumen communicating with an interior ofsaid balloon, said first lumen having a closable valve; iii) a secondlumen extending from past said proximal end of said balloon to past saiddistal end of said balloon, said second lumen having a capped distal tipand one or more ports adjacent said capped distal tip and distal to saidballoon; b) allowing rectal gas to exit the rectum via said one or moreports until no further exiting gas is evident; c) inflating said balloonsufficiently to immobilize said prostate; d) treating said prostate withXRT; and e) allowing rectal gas to exit the rectum via said one or moreports during said treatment.
 3. The method of claim 2, said balloonfurther comprising one or more fiducial markers, and said method furthercomprises determining the position of said one or more fiducial markersand positioning said balloon such that said fiducial markers are in adesired position.
 4. The method of claim 2, said balloon furthercomprising a locking device on said first lumen, and said method furthercomprising reproducibly positioning and locking said locking device onsaid first lumen.
 5. The method of claim 2, wherein: a) said ballooncomprising one or more fiducial markers, and said method furthercomprising determining the position of said one or more fiducial markersand positioning said balloon such that said fiducial markers are in adesired position; b) said balloon comprising a locking device andnumerical indicia on said first lumen, and said method furthercomprising reproducibly positioning and locking said locking device onsaid first lumen.
 6. The method of claim 2, said balloon furthercomprising a radiation sensor thereon, said method further comprisingmeasuring a dosage of said XRT with said radiation sensor and stoppingsaid XRT when said measured dosage reaches a desired dosage amount.
 7. Amethod of treating prostate cancer, said method comprising: a) insertinga prostate immobilizing balloon into the rectum of a patient; i) saidballoon being shaped and sized to immobilize a prostate when inflated;ii) said balloon further comprising a gas releasing fluid passagewayextending from beyond a distal end of said balloon to beyond a proximalends of said balloon, said passageway having a closed distal tip and oneor more ports distal to said balloon; b) allowing rectal gas to exit therectum via said one or more ports; c) inflating said balloonsufficiently to compress and immobilize said prostate; d) treating saidprostate plus a margin of surrounding tissue with XRT; e) wherein saidmargin is smaller than it would be with a comparable balloon lackingsaid gas releasing fluid passageway.
 8. The method of claim 7, saidballoon further comprising one or more fiducial markers, and said methodfurther comprises determining the position of said one or more fiducialmarkers and positioning said balloon such that said fiducial markers arein a desired position.
 9. The method of claim 7, said balloon furthercomprising a locking device on said first lumen, and said method furthercomprising reproducibly positioning and locking said locking device onsaid first lumen.
 10. The method of claim 7, a) said balloon comprisingone or more fiducial markers, and said method further comprisingdetermining the position of said one or more fiducial markers andpositioning said balloon such that said fiducial markers are in adesired position; b) said balloon further comprising a locking deviceand numerical indicia on said first lumen, and said method furthercomprising reproducibly positioning and locking said locking device onsaid first lumen.
 11. The method of claim 7, said balloon furthercomprising a radiation sensor thereon, said method further comprisingmeasuring a dosage of said XRT with said radiation sensor and stoppingsaid XRT when said measured dosage reaches a desired dosage amount.